Table 7.

Baseline characteristics and surgical outcomes in the patients of BCLC C stage

	Conversion treatment group (n=16)	Control group (n=21)	t/Z/χ2	P value
Age, years, n			0.03	0.57
< 65	11	15
≥65	5	6
Sex, n			0.13	0.6
Male	15	19
Female	1	2
The operation time, min	236.06±63.83	195±63.72	1.94	0.06
The mean blood loss, ml	146.88±64.47	113.5±56.31	-1.47	0.14
The postoperative hospital stay, days	11.69±2.75	10.14±3.77	1.38	0.18
The abdominal drainage time, days	8.53±3.62	5.9±2.99	2.36	0.03
ΔRBC%	-8.6 (-17.4~-3.1)	-7.2 (-12.6~-1.2)	-1.42	0.16
ΔHB%	-8.3 (-16.3~-1.2)	-6.71 (-11.9~-1.4)	-1.02	0.31
ΔALT%	881.46(366.94~1820.15)	743.31(350.19~1263.12)	-0.89	0.37
ΔAST%	832.52(380.45~2341.99)	655.51(373.75~1088.99)	-0.64	0.52
Δ Bilirubin%	69.78 (34.81~120.02)	34.62 (-1.74~94.28)	-1.07	0.28
Δ Albumin%	-13.53 (-19.98~-4.19)	-21.59 (-26.1~-15.23)	-2.33	0.02
Postoperative complications	12 (n=9)	19 (n=12)	0.003	0.61
Fever caused by infection	2	4
Biliary leakage	1	0
Hypoproteinemia	2	4
Massive ascites	1	7
Spontaneous bacterial peritonitis	1	1
Hydrothorax	1	2
Kaliopenia	3	0
Pneumonia	0	1
Incision seepage	1	0